Niels Bergenhem

Title: Niels Bergenhem: Innovator in Cell Motility and Intracellular Signaling

Introduction

Niels Bergenhem is a notable inventor based in Frederiksberg C, Denmark. He has made significant contributions to the field of cellular biology, particularly in the area of cell motility and intracellular signaling. With a total of 2 patents, Bergenhem's work has the potential to impact therapeutic approaches in various medical conditions.

Latest Patents

Bergenhem's latest patents include innovative methods for modifying cell motility using factor VIIa or inactivated factor VIIa. This invention provides methods for altering the motility of tissue factor (TF)-expressing cells by contacting them with an effective amount of Factor VIIa or a Factor VIIa agonist. Another significant patent focuses on the identification of drug candidates that modulate factor VII-mediated intracellular signaling. This invention outlines methods for identifying candidate drugs that influence factor VIIa-mediated intracellular signaling by measuring their effects on the activation of the mitogen-activated protein kinase (MAP kinase) signaling pathway.

Career Highlights

Throughout his career, Niels Bergenhem has worked with prominent companies in the pharmaceutical industry, including Novo Nordisk A/S and Novo Nordisk Healthcare AG. His experience in these organizations has allowed him to develop and refine his innovative ideas, contributing to advancements in medical science.

Collaborations

Bergenhem has collaborated with esteemed colleagues such as Lars Kongsbak and Lars Christian Petersen. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and the development of groundbreaking solutions in the field.

Conclusion

Niels Bergenhem's contributions to the field of cellular biology through his patents and collaborations highlight his role as an influential inventor. His work continues to pave the way for advancements in medical therapies and drug development.